ScholarIQanswers from OpenAlex

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease

PaperCitations, authors & open-access status

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease have?

ScholarIQcitation count

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease has 163 citations in the OpenAlex counts ScholarIQ stores.

When was Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease published?

ScholarIQyear

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease has 2006 year in the ScholarIQ index.

What is the open-access status of Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease?

ScholarIQoa status

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease has closed oa status in the ScholarIQ index.

What is the DOI of Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease?

ScholarIQdoi

The DOI for Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease is on the source record.

What is the PMID of Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease?

ScholarIQpmid

The PMID for Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease is on the source record.

What is the OpenAlex record for Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease?

ScholarIQopenalex

The OpenAlex for Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial